出生前遺伝子検査の世界市場：2026年までの予測

世界の出生前遺伝子検査における新たな技術的進歩には、次世代シーケンサー（NGS）技術、染色体マイクロアレイ解析（CMA）ツール、PCR TaqManの強化が含まれます。これらは、ゲノムプロファイリングの精度と特異性を向上させ、検査の効率と信頼性を増強し、ワークフローを合理化するものです。

当レポートでは、世界の出生前遺伝子検査市場について調査分析し、成長予測、課題、主要ベンダー概要、市場集中度、成長戦略などの情報を提供しています。

目次

戦略的必須事項

• 成長がますます困難になっているのはなぜか？
• The Strategic Imperative 8（TM）
• 出生前遺伝子検査に対する上位3つの戦略的必須事項の影響
• 成長機会がGrowth Pipeline Engine（TM）を促進

成長機会分析

• 分析範囲
• セグメンテーション
• 競合情勢：地域別スナップショット
• 成長指標
• 成長促進要因
• 成長抑制抑制
• 米国の中絶法の変更が世界に与える影響
• 予測の前提条件
• 収益予測
• 収益予測：検査の種類別
• 収益予測：地域別
• 収益予測分析
• 価格動向と予測分析
• 競合環境
• 収益シェア
• 収益シェア分析

成長機会分析：スクリーニング検査

• 成長指標
• 収益予測
• 収益予測：地域別

成長機会分析：NIPT

• NIPT市場概要
• 成長指標
• 収益予測
• 予測分析

成長機会分析：キャリアスクリーニング検査

• キャリアスクリーニング検査の市場概要
• 成長指標
• 収益予測
• 予測分析

成長機会分析：診断検査

• 成長指標
• 収益予測
• 収益予測：地域別

成長機会分析：侵襲的検査

• 侵襲的検査市場概要
• 成長指標
• 収益予測
• 予測分析

成長機会分析：流産検査

• 流産検査市場概要
• 成長指標
• 収益予測
• 予測分析

成長機会領域

• 成長機会1：eコマースと消費者直販
• 成長機会2：技術の進歩と低コストのソリューション
• 成長機会3：パートナーシップと合弁事業

次のステップ

Innovation Culture in Screening Drives Prenatal Genetic Testing Growth and Makes it Accessible to More Patients

New technological advances in prenatal genetic testing include the enhancement of the next-generation sequencing (NGS) technology, chromosomal microarray analysis (CMA) tool, and PCR TaqMan. These improve precision and specificity in genome profiling, augment the efficiency and reliability of testing, and streamline workflow.

The study will help prenatal genetic testing providers understand the key trends emerging in the market (for the various prenatal tests offered in different geographic regions). It provides information on the state of the market and estimates its growth for the next 5 years, and it lists the unmet needs that companies must work on for their continuous growth. In addition, the study provides an overview of the major vendors offering tests, their market concentration, and different growth strategies.

The research service guides prenatal genetic testing providers in mapping strategic priorities and developing new capabilities to capitalize on emerging growth opportunities in this market based on current and expected numbers.

Table of Contents

Strategic Imperatives

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on Prenatal Genetic Testing
• Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

• Scope of Analysis
• Segmentation
• Competitive Landscape: Regional Snapshot
• Growth Metrics
• Growth Drivers
• Growth Restraints
• Global Impact of Changes in the US Abortion Law
• Forecast Assumptions
• Revenue Forecast
• Revenue Forecast by Type of Test
• Revenue Forecast by Type of Test (continued)
• Revenue Forecast by Type of Test (continued)
• Revenue Forecast by Region
• Revenue Forecast Analysis
• Pricing Trends and Forecast Analysis
• Competitive Environment
• Revenue Share
• Revenue Share Analysis

Growth Opportunity Analysis: Screening Tests

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region

Growth Opportunity Analysis: NIPT

• NIPT Market Overview
• Growth Metrics
• Revenue Forecast
• Forecast Analysis

Growth Opportunity Analysis: Carrier Screening Test

• Carrier Screening Test Market Overview
• Growth Metrics
• Revenue Forecast
• Forecast Analysis

Growth Opportunity Analysis: Diagnostic Tests

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region

Growth Opportunity Analysis: Invasive Test

• Invasive Tests Market Overview
• Growth Metrics
• Revenue Forecast
• Forecast Analysis

Growth Opportunity Analysis: Miscarriage Test

• Miscarriage Test Market Overview
• Growth Metrics
• Revenue Forecast
• Forecast Analysis

Growth Opportunity Universe

• Growth Opportunity 1: eCommerce and Direct-to-consumer Sales
• Growth Opportunity 1: eCommerce and Direct-to-consumer Sales (continued)
• Growth Opportunity 2: Technological Advancement and Low-Cost Solutions
• Growth Opportunity 2: Technological Advancement and Low-Cost Solutions (continued)
• Growth Opportunity 3: Partnerships and Joint Ventures
• Growth Opportunity 3: Partnerships and Joint Ventures (continued)

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• List of Exhibits
• List of Exhibits (continued)
• Legal Disclaimer